The global Migraine Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during.....
SynopsisNeonatal ventilators provide ventilatory support to preterm and critically ill infants who suffer from respiratory failure and who generally have low-compliance lungs, small tidal volumes, high airway resistance, and high respiratory rates. Volume-targeted ven.....
SynopsisOrganic capsule is a kind of capsule, compared to ordinary capsule, it is more natural alternative, starch-free, gluten-free, preservative-free, vegetable origin and non-GMO. The global Organic Capsules market size is expected to reach US$ million by 202.....
SynopsisFampridine are three isomers that are used as research tools to characterize potassium channel subtypes, as drugs for the treatment of some of the symptoms of multiple sclerosis, and on the surface for adults with some diseases. has improved. The global .....
SynopsisVortioxetine is an atypical antipsychotic and antidepressant indicated for the treatment of major depressive disorder (MDD). It is classified as a serotonin modulator and simulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotra.....
SynopsisRapid microbial detection methods enable users to detect microbial contamination in a matter of hours as opposed to the days required for traditional methods. The global Rapid Microbial Detection Systems market size is expected to reach US$ million by 20.....
SynopsisThe global Minimally Invasive Glaucoma Surgery Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were co.....
Synopsis Cefaclor Capsules are a semisynthetic cephalosporin antibiotic for oral administration. It is used to treat certain infections caused by bacteria. Global Cefaclor Capsules market is projected to reach US$ million in 2029, increasing from.....
Synopsis Global Rehabilitation Assistive Devices market is projected to reach US$ 492 million in 2029, increasing from US$ 330 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COV.....
Synopsis Highlights The global Flurbiprofen Axetil Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of .....
